JPH08151323A - Method for treating and preventing swine respiratory organ disease and therapeutic agent therefor - Google Patents

Method for treating and preventing swine respiratory organ disease and therapeutic agent therefor

Info

Publication number
JPH08151323A
JPH08151323A JP29141894A JP29141894A JPH08151323A JP H08151323 A JPH08151323 A JP H08151323A JP 29141894 A JP29141894 A JP 29141894A JP 29141894 A JP29141894 A JP 29141894A JP H08151323 A JPH08151323 A JP H08151323A
Authority
JP
Japan
Prior art keywords
pigs
respiratory
glutaral
diluted
swine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP29141894A
Other languages
Japanese (ja)
Other versions
JP2637703B2 (en
Inventor
Toku Ueichi
▲徳▼ 上市
Futao Mimura
二雄 三村
Yoichi Sato
洋一 佐藤
Takenori Saiga
丈範 齋賀
Yoichiro Tsubaki
洋一郎 椿
Junichi Takada
純一 高田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zenyaku Kogyo Co Ltd
Yashima Sangyo Co Ltd
Original Assignee
Nippon Zenyaku Kogyo Co Ltd
Yashima Sangyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zenyaku Kogyo Co Ltd, Yashima Sangyo Co Ltd filed Critical Nippon Zenyaku Kogyo Co Ltd
Priority to JP29141894A priority Critical patent/JP2637703B2/en
Publication of JPH08151323A publication Critical patent/JPH08151323A/en
Application granted granted Critical
Publication of JP2637703B2 publication Critical patent/JP2637703B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: To obtain a therapeutic agent capable of killing the causal bacteria of swine respiratory organ diseases, reducing the death selection rate, relieving the lesions of swine lungs and nasal cavities, and consequently achieving economical effects such as the stimulation of the growth, the improvement of feed demand rate and the shortage of shipment age in day. CONSTITUTION: A disinfectant, glutaral, is diluted with water containing a buffering agent. The obtained dilution solution is fogged in a particle diameter of <=10μm with a fogging machine or a high pressure atomizer and sucked by a swine. Thereby, the fog particles intrude into the respiratory bronchial tubes of the swine lower respiratory tract and further into the alveoli to kill respiratory organ disease-causing bacteria: Mycoplasma hyopneumoniae, Pasteurella multocida, Actinobacillus pluropneumoniae, Himophilas parasis, Bordetella bronchiseptica, etc., which always live in the swine.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、豚の呼吸器病を治療す
るための治療・予防方法及び治療剤に関するものであ
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for treating and preventing respiratory diseases in pigs and a therapeutic agent.

【0002】[0002]

【従来の技術】豚の病気では、呼吸器病と下痢がすぐ頭
に浮かぶほど一般に良く知られており、これらの病気は
野外で多発しており、このうち下痢は近年減少しつつあ
り、また寄生虫病(トキソプラズマ病、回虫、肺虫、パ
ラチジウムなど)は依然として存在するもののその損失
は呼吸器病に比べると極めて少ない。
2. Description of the Related Art In pig diseases, respiratory diseases and diarrhea are so well known that they immediately come to mind, and these diseases occur frequently in the field, of which diarrhea has been decreasing in recent years. Parasitic diseases (such as toxoplasmosis, roundworm, lungworm, paratidium, etc.) are still present, but their loss is very small compared to respiratory diseases.

【0003】呼吸器病としてウイルス性(インフルエン
ザ)、細菌性としてM.hn(マイコプラズマ・ハイオ
ニューモニエ)、P.m(パスツレラ・マルトシダ)、
A.PP(アクチノバチルスプルロニューモニエ)、
H.PS(ヘモフィルスパラスイス)、B.b(ボルデ
テーラブロンキセプテカ)、AR(萎縮性鼻炎)などは
殆どの豚の呼吸器道に常在化しており、SPF豚(特定
病原不在豚)といえども慢性の日和見感染症(P.m、
A.PP、H.PSなど)は常在化していることが多
い。
The respiratory disease is viral (influenza) and the bacterial disease is M. hn (Mycoplasma hyopneumoniae), P. m (pasturera multocida),
A. PP (Actinobacillus pleuroneumonier),
H. PS (Hemophilus parasuisse), B.I. b (Boldetella bronchicepteca), AR (atrophic rhinitis), etc. are resident in the respiratory tract of most pigs, and even in SPF pigs (specific pathogen-free pigs), chronic opportunistic infections ( P.m.
A. PP, H.M. (PS etc.) is often resident.

【0004】これらの呼吸器病による損失は、繁殖豚や
肥育豚に発生して大きな被害を与えており、これらの病
気の予防治療には、グラム陰性陽性菌に作用する懸濁水
性マイシリン、クロラムフェニコール、ビコザマイシ
ン、スルファモノメトキシン、チアムリン、メタシリナ
ム、クロルテトラサイクリン、オキシテトラサイクリ
ン、アモキシリン、オキソリン酸、スルファモノメトキ
シン等が、注射、内服、飼料添加剤として使用されてい
る。
Loss due to these respiratory diseases causes serious damage to breeding pigs and fattening pigs, and for the prevention and treatment of these diseases, suspended aqueous mycillin, which acts on Gram-negative positive bacteria, and black Rumphenicol, vicozamycin, sulfamonomethoxine, tiamulin, metacylinum, chlortetracycline, oxytetracycline, amoxyline, oxophosphoric acid, sulfamonomethoxine and the like are used as injection, oral administration and feed additives.

【0005】また、豚舎などの消毒には、逆性石鹸、両
性石鹸、オルソ剤、ヨードホールなどが使用されている
が、満足した効果をあげていないのが現状である。即
ち、畜舎用として用いられている消毒剤には、どんな条
件の中でも殺菌力が低下することがないようなものが特
に望まれるが、そのような条件を満足する消毒剤はなか
なか出現しなかった。
[0005] Further, for disinfection of pig houses and the like, inverse soaps, amphoteric soaps, ortho agents, iodine holes and the like are used, but at present, satisfactory effects have not been obtained. In other words, a disinfectant used for livestock barn is particularly desired to have a sterilizing power that does not decrease under any conditions, but disinfectants satisfying such conditions have not easily appeared. .

【0006】[0006]

【発明が解決しようとする課題】上記したように、豚の
呼吸器病には各種の抗生物質の注射や経口投与、飼料添
加が行われているが、満足する効果を発揮しておらず、
また豚舎の消毒も行われているが、これらの消毒剤によ
り呼吸器道に常在化している呼吸器病の起因菌を死滅さ
せるような効果を期待するような考えや報告は存在しな
い。
As described above, injection, oral administration, and feed addition of various antibiotics have been performed for respiratory diseases of pigs, but they have not exhibited satisfactory effects.
Although piggeries are also disinfected, there is no idea or report that these disinfectants are expected to have the effect of killing bacteria that cause respiratory diseases that are resident in the respiratory tract.

【0007】本発明者等は、発想を変えて、豚舎で使用
されている消毒剤グルタラールを用いて、豚の呼吸器病
を治療・予防できないかと考え、鋭意研究の結果、消毒
剤グルタラールを用いて豚の呼吸器病の起因菌(気道常
在菌)を死滅させることができることを見出して本発明
を完成した。
The inventors of the present invention changed their ideas and thought that it would be possible to treat and prevent respiratory diseases in pigs using the disinfectant glutaral used in the piggery. Thus, the present inventors have found that bacteria that cause respiratory illness in pigs (resident bacteria in the respiratory tract) can be killed and completed the present invention.

【0008】[0008]

【課題を解決するための手段】請求項1の発明は、消毒
剤グルタラールを緩衝剤を加えた水で希釈し、得られた
希釈液を煙霧機又は高圧微細機を用いて粒子径10μ以
下で煙霧し、豚に吸引させることにより豚の下部気道の
呼吸性気管支、更に肺胞まで煙霧粒子を侵入させて、豚
に常在する呼吸器病起因菌M.hn(マイコプラズマ・
ハイオニューモニエ)、P.m(パスツレラ・マルトシ
ダ)、A.PP(アクチノバチルスプルロニューモニ
エ)、H.PS(ヘモフィルスパラスイス)、B.b
(ボルデテーラブロンキセプテカ)等を死滅させること
を特徴とする豚の呼吸器病の治療方法である。
According to a first aspect of the present invention, the disinfectant glutaral is diluted with water containing a buffer, and the resulting diluted liquid is used with a smoke atomizer or a high-pressure micromachine to make the particle diameter 10 μm or less. By inhaling fumes and inhaling them into the respiratory tracts of the lower respiratory tract of the pigs, as well as into the alveoli, inhaling fumes particles, the respiratory pathogens M. hn (Mycoplasma
High Pneumoniae), P. m (pasturera maltocida), A. PP (Actinobacillus pleuropneumoniae), H.P. PS (Hemophilus parasuisse), B.I. b
(Bordetera Bronquiseptica) is a method of treating respiratory diseases in pigs, which is characterized by dying.

【0009】請求項2の発明は、グルタラール25%含
有製剤を、該グルタラール製剤と略等量の緩衝剤を加え
た水で10〜100倍に希釈した希釈液を用いることを
特徴とする豚の呼吸器病の治療方法である。
The invention of claim 2 is characterized by using a diluent obtained by diluting a preparation containing 25% glutaral with water to which a buffer of substantially the same amount as that of the glutaral preparation is added by 10 to 100 times. This is a method for treating respiratory diseases.

【0010】請求項3の発明は、豚舎100坪当り調整
した希釈液を0.5L〜10L煙霧することを特徴とす
る豚の呼吸器病の治療方法である。
A third aspect of the present invention is a method for treating respiratory disease in pigs, which comprises spraying 0.5L to 10L of the diluted liquid per 100 tsubo of pig pen.

【0011】請求項4の発明は、調整した希釈液を定期
的に煙霧することにより豚の呼吸器病を予防することを
特徴とする豚の呼吸器病の予防方法である。
A fourth aspect of the present invention is a method for preventing respiratory disease in pigs, which comprises periodically fogging the adjusted diluent to prevent respiratory disease in pigs.

【0012】請求項5の発明は、粒子径10μ以下で煙
霧し豚に吸引させることにより豚の下部気道の呼吸性気
管支、更に肺胞まで煙霧粒子を侵入させて、豚に常在す
る呼吸器病起因菌M.hn(マイコプラズマ・ハイオニ
ューモニエ)、P.m(パスツレラ・マルトシダ)、
A.PP(アクチノバチルスプルロニューモニエ)、
H.PS(ヘモフィルスパラスイス)、B.b(ボルデ
テーラブロンキセプテカ)等を死滅させるための治療剤
であって、グルタラール25%含有製剤を該グルタール
製剤と略等量の緩衝剤を加えた水で10〜100倍に希
釈してなることを特徴とする豚の呼吸器病の治療剤であ
る。
[0012] The invention of claim 5 is a respirator which is present in a pig, which is caused by inhaling fumes with a particle size of 10 μm or less and inhaling them into the respiratory bronchi of the lower respiratory tract of the pig and further into the alveoli. Disease-causing bacterium M. hn (Mycoplasma hyopneumoniae), P. m (pasturera multocida),
A. PP (Actinobacillus pleuroneumonier),
H. PS (Hemophilus parasuisse), B.I. b (Bordetera Bronxepteca) and the like, which is a therapeutic agent for killing glutaral 25%, is diluted 10 to 100 times with water containing a buffer agent in an amount approximately equal to that of the glutaral preparation. It is a therapeutic agent for respiratory diseases in pigs characterized by

【0013】[0013]

【作用】本発明では、消毒剤グルタラールを緩衝剤を加
えた水で希釈し、得られた希釈液を煙霧機又は高圧微細
機を用いて粒子径10μ以下で煙霧し、豚に吸引させる
ことにより豚の下部気道の呼吸性気管支、更に肺胞まで
煙霧粒子を侵入させて、豚に常在する呼吸器病起因菌
M.hn(マイコプラズマ・ハイオニューモニエ)、
P.m(パスツレラ・マルトシダ)、A.PP(アクチ
ノバチルスプルロニューモニエ)、H.PS(ヘモフィ
ルスパラスイス)、B.b(ボルデテーラブロンキセプ
テカ)等を死滅させることができ、よって豚のへい死、
淘汰率の減少、肺及び鼻腔の病変の軽減が認められ、そ
の結果発育の促進、飼料要求率の改善及び出荷日令の短
縮など経済的効果を発揮することができる。
In the present invention, the disinfectant glutaral is diluted with water to which a buffer is added, and the resulting diluted solution is atomized with a mist or a high-pressure micromachine to a particle size of 10 μm or less, and sucked by a pig. The respiratory tract of the lower respiratory tract of pigs is infiltrated with mist particles into the respiratory tract and further into the alveoli. hn (Mycoplasma hyopneumoniae),
P. m (pasturera maltocida), A. PP (Actinobacillus pleuropneumoniae), H.P. PS (Hemophilus parasuisse), B.I. b (Bordetera Bronquiseptica) etc. can be killed, so that the pig is killed,
Reduction of selection rate and reduction of lesions of lung and nasal cavity are observed, and as a result, economic effects such as promotion of growth, improvement of feed requirement rate and shortening of shipping date can be exhibited.

【0014】本発明に用いられるグルタラール製剤とし
ては、グルタクリーン(ヤシマ産業株式会社製・商品
名)とグルターZ(ヤシマ産業株式会社製・商品名)が
知られている。
As glutaral preparations used in the present invention, glutaclean (trade name, manufactured by Yashima Sangyo Co., Ltd.) and glutar Z (trade name, manufactured by Yashima Sangyo Co., Ltd.) are known.

【0015】グルタクリーンは、グルタルアルデヒド
(一般名グルタラール)製剤(グルタラール25%含有
製剤)で、動物用医薬品として世界で初めて実用化され
た殺菌消毒剤である。またグルタクリーンは、有機物共
存下でも殺菌力の低下がない、まさに畜産用として最適
の消毒剤である。また成分はアルデヒドの一種である
が、ホルマリン(ホルムアルデヒド)のように強い刺激
臭もない。
Glutaclean is a glutaraldehyde (general name: glutaral) preparation (a preparation containing 25% glutaral), which is the world's first bactericidal disinfectant for veterinary medicine. Glutaclean is also the best disinfectant for livestock, with no reduction in bactericidal activity even in the presence of organic substances. The component is a kind of aldehyde, but does not have a strong pungent odor like formalin (formaldehyde).

【0016】また、グルターZは、グルタラールの含有
量はグルタクリーンと略等量であるが、グルターZの緩
衝剤が液体であるために希釈のための溶解が容易であり
取扱いも簡単である。
Glutar Z has a glutaral content substantially equal to that of glutaclean. However, since the buffer of glutar Z is a liquid, dissolution for dilution is easy and handling is simple.

【0017】上記グルタクリーン及びグルターZは、動
物用医薬品として畜舎、鶏舎及び設備、種卵、養鶏用器
具機材の消毒の効能効果が承認されている。以下に、通
常に用いられているグルタクリーン及びグルターZの成
分分量、用法用量、グルタラールの殺菌スペクトルにつ
いて説明する。
The above-mentioned glutaclean and gluter Z have been approved as animal medicines for disinfecting livestock houses, poultry houses and equipment, eggs, and poultry raising equipment. Hereinafter, the component amounts of glutaclean and glutar Z, the dosage, and the germicidal spectrum of glutaral, which are commonly used, will be described.

【0018】1)成分分量 グルタクリーン(主剤)100mL(ミリリットル)
中グルタルアルデヒド(グルタラール)25gを含有す
る。 (緩衝剤)100g中炭酸水素ナトリウム60g、炭酸
ナトリウム40gを含有する。 グルターZ(主剤)100mL中グルタルアルデヒド
25gを含有する。(緩衝剤)300mL中酢酸カリウ
ム125g、リン酸二ナトリウム34gを含有する。
1) Amount of ingredients Glutaclean (main ingredient) 100 mL (milliliter)
Contains 25 g of medium glutaraldehyde (glutaral). (Buffer) Contains 60 g of sodium bicarbonate and 40 g of sodium carbonate in 100 g. Glutar Z (main ingredient) contains 25 g of glutaraldehyde in 100 mL. (Buffer) Contains 300 g of potassium acetate and 34 g of disodium phosphate in 300 mL.

【0019】2)用法用量 グルタクリーンは用時調整の製剤である。グルタクリ
ーン製剤を目的に応じて水で希釈する。希釈液10L
(リットル)当たりグルタクリーン緩衝剤1.5gを混
和して使用する。但し手術、解剖器具器材の消毒につい
て使用する場合は、希釈液10L当りグルタクリーン緩
衝剤25.5gを加えて使用する。
2) Dosage Glutaclean is a preparation that is adjusted when used. The glutaclean formulation is diluted with water as desired. Diluent 10L
Mix and use 1.5 g of glutaclean buffer per liter. However, when used for surgery or disinfection of dissection instruments and equipment, add 25.5 g of glutaclean buffer per 10 L of diluent.

【0020】[グルタクリーンの使用方法][How to use GlutaClean]

【表1】 [Table 1]

【0021】グルターZは用時調整の製剤である。グ
ルターZ主剤を目的に応じて水で希釈する。希釈液10
L当り緩衝剤7.5mLを混和して使用する。但し、手
術解剖器具機材の消毒について使用する場合は、希釈液
1L当りグルターZ緩衝剤30mLを加え混和して使用
する。
Gluter Z is a preparation for use at the time of use. The gluter Z base is diluted with water according to the purpose. Diluent 10
Mix and use 7.5 mL of buffer per L. However, when used for disinfection of surgical dissection equipment, add and mix 30 mL of gluter Z buffer per 1 L of diluent.

【0022】[グルターZの使用方法][How to Use Gluter Z]

【表2】 グルターZは液体なので溶解しやすく、取り扱いも簡単
であり、細霧消毒に適している。
[Table 2] Since gluter Z is a liquid, it is easily dissolved and easy to handle, and is suitable for fine mist disinfection.

【0023】3)グルタラールの殺菌スペクトル3) Sterilization spectrum of glutaral

【表3】 上記の通り、グルタラールは畜舎、鶏舎の消毒に使用さ
れているが、殺菌スペクトルはグラム陰性菌、グラム陽
性菌、眞菌及びウイルスと広範囲に及ぶ消毒剤である。
[Table 3] As mentioned above, glutaral is used for disinfection of livestock and poultry houses, but its disinfection spectrum is a wide range of disinfectants, including gram-negative bacteria, gram-positive bacteria, fungi and viruses.

【0024】本発明者等は、この消毒剤グルタラールを
直接豚に吸入させることにより、呼吸器病の起因菌を死
滅させ、豚の呼吸器病を治療・予防できるのではないか
と種々検討した結果、グルタラールの希釈液を煙霧機や
高圧微細機で粒子を10μ以下として豚舎で煙霧するこ
とにより、豚の下部気道の呼吸性気管支、更に肺胞まで
煙霧粒子を侵入させ、常在する呼吸器病起因菌M.hn
(マイコプラズマ・ハイオニューモニエ)、P.m(パ
スツレラ・マルトシダ)、A.PP(アクチノバチルス
プルロニューモニエ)、H.PS(ヘモフィルスパラス
イス)、B.b(ボルデテーラブロンキセプテカ)など
を死滅させることができることを見出した。
As a result of various studies, the inventors of the present invention have conducted various investigations to directly inhale this disinfectant glutaral into pigs to kill the bacteria causing respiratory diseases and to treat / prevent respiratory diseases in pigs. , Glutaral diluting solution with a mist or high-pressure micromachine to reduce particle size to less than 10μ in a pig house to cause inhalation of respiratory particles in the lower respiratory tract of the pig and further into the alveoli, resulting in persistent respiratory disease. The causative bacterium M. hn
(Mycoplasma hyopneumoniae), P. m (pasturera maltocida), A. PP (Actinobacillus pleuropneumoniae), H.P. PS (Hemophilus parasuisse), B.I. It has been found that b (Boldetella bronchiseptica) and the like can be killed.

【0025】また、これらの起因菌の死滅により、呼吸
器病の予防、及び治療ができることを見出した。
It was also found that the death of these causative bacteria can prevent and treat respiratory diseases.

【0026】[0026]

【実施例】以下、本発明における試験例、及び実施例を
説明する。 <試験例> 試験例I グルタラールの希釈液について 前記2)用法用量で示したグルタクリーン及びグルター
Zの用法用量から、グルタクリーン及びグルターZを1
0〜100倍に希釈するのが適当と考え、またグルタラ
ール緩衝剤は、グルタクリーン及びグルターZの使用量
と等量とすることが適当と考えて、希釈液を調整した。 粒子径について 上記で調整した希釈液を、100坪当り5Lになるよう
に噴霧機で噴霧(粒子径100μ以上)、及び細霧機で
細霧(粒子径11〜99μ程度)した(対照)。また、
上記希釈液を、100坪当り5Lになるように煙霧機で
煙霧(粒子径10μ以下)、及び高圧微細機で煙霧(粒
子径10μ以下)した(本発明)。
EXAMPLES Test examples and examples in the present invention will be described below. <Test Example> Test Example I Regarding Glutaral Diluted Solution From the dosages of Glutaclean and Gluter Z shown in 2) above, 1 of Glutaclean and Gluter Z was used.
It was considered appropriate to dilute it 0 to 100 times, and the glutaral buffer was considered to be equivalent to the amounts of glutaclean and gluta Z used. Particle Size The diluted solution prepared above was sprayed with a sprayer (particle size 100 μm or more) so as to be 5 L per 100 tsubo, and finely atomized with a fine mist (particle size 11 to 99 μm) (control). Also,
The above diluted solution was fogged (particle size: 10 μm or less) by a haze machine and 5 μm (particle size: 10 μm or less) by a high-pressure micromachine so that the diluted solution became 5 L per 100 tsubo (invention).

【0027】上記粒子径の違いによる下部気道における
呼吸器起因菌を抜取り検査することにより抑制効果を比
較してその結果を表4に示した。表中の数字は検出数/
検査頭数を表わす。
The inhibitory effects were compared by sampling and examining the respiratory pathogens in the lower respiratory tract due to the difference in particle size. The results are shown in Table 4. The numbers in the table are the number of detections /
Indicates the number of test animals.

【表4】 (注)P.m :パスツレラ症 A.PP:胸膜肺炎 H.PS:グレーサー病 抜取検査を行った上記試験により、粒子径を10μ以下
で煙霧すると、下部気道の呼吸性気管支炎、更に肺胞ま
でグルタラールの粒子が侵入し、呼吸器病の起因菌を死
滅させ、呼吸器病を治療できることがわかった。また豚
の体重も増加することが分かった。上記煙霧を定期的に
実施することにより、呼吸器病を予防できることも判明
した。これに対して前記対照は、呼吸器病の起因菌を効
果的に死滅させることができなかった。これは、噴霧及
び細霧では粒子径が大きいために、粒子が豚の呼吸器道
の奥まで侵入することができず、そのために充分な効果
が得られないものと考えられる。従って噴霧或いは細霧
では気道内における呼吸器病の抑制はできないものと判
断される。
[Table 4] (Note) P. m: Pasteurellosis A. PP: Pleural pneumonia H. PS: Glacer's disease According to the above-mentioned test that conducted a sampling test, if the particle size is 10 μm or less, it causes respiratory bronchitis in the lower respiratory tract, and glutaral particles invade the alveoli to kill the bacteria causing respiratory diseases. , I found that I could treat respiratory diseases. The pigs were also found to gain weight. It has also been found that regular use of the fumes can prevent respiratory diseases. In contrast, the control failed to effectively kill the causative organism of the respiratory disease. It is considered that this is because the particles cannot penetrate deep into the respiratory tract of the pig due to the large particle size in the case of spraying and fine mist, and therefore a sufficient effect cannot be obtained. Therefore, it is judged that the respiratory illness in the respiratory tract cannot be suppressed by spraying or fine mist.

【0028】試験例II グルタラールの豚舎での煙霧試験 1)豚舎 136坪 肥育豚56頭 豚舎は12m×37.6m=451.2m2(136.
7坪)であり、中央通路の両側に、各4室計8室の豚房
が高さ1mの囲いで囲われて形成されており、各豚房に
は夫々7頭の豚が飼育されていて、各豚房の上部は連通
している。 2)薬剤の調製 ・グルターZ25倍希釈液 グルターZ主剤2.8L、緩衝液2.8Lを水で希釈し
て70Lとする。 ・グルターZ50倍希釈液 グルターZ主剤1.4L、緩衝液1.4Lを水で希釈し
て70Lとする。 ・グルターZ100倍希釈液 グルターZ主剤0.7L、緩衝液0.7Lを水で希釈し
て70Lとする。 3)豚舎一棟当たり煙霧薬剤量13.6L(0.1L/
坪) 4)散布方法 散布者はゴム手袋と防塵マスクを装着し、散布用煙霧機
を持ち中央通路から左右の豚房に交互に煙霧した。煙霧
時間は1豚房当たり約5分間であった。 5)作業員の個人暴露濃度測定 今回の試験に際し、供試薬剤希釈率25倍、50倍、1
00倍の散布作業における作業者のグルタラール個人暴
露濃度はそれぞれ0.24ppm、0.18ppm、
0.1ppmであり、希釈倍率が低いほど暴露濃度は高
濃度であった。暴露保護のために保護具の装着は必要と
思われたが、作業者には異常は認められなかった。
Test Example II Haze test in a pig house of glutaral 1) Pig house 136 tsubo 56 fattening pigs The pig house was 12 mx 37.6 m = 451.2 m 2 (136.
Each of the pigs has a total of 8 pigs in each of the four rooms on each side of the central aisle, surrounded by a 1-meter-high fence, and each pig holds 7 pigs. The upper part of each pig bun communicates. 2) Preparation of drug-Gluter Z 25-fold diluted solution 2.8 L of gluter Z main agent and 2.8 L of buffer solution are diluted with water to 70 L. -Gluter Z 50-fold diluted solution 1.4 L of gluter Z main agent and 1.4 L of buffer solution are diluted with water to 70 L. -Gluter Z 100-fold diluted solution 0.7 L of gluter Z base and 0.7 L of buffer solution are diluted with water to 70 L. 3) Amount of fumes medicine per pig house 13.6L (0.1L /
4) Spray method 4) Sprayers wore rubber gloves and a dust mask, held a spray fume machine, and smoked alternately from the central passage to the left and right pig bunches. The fume time was about 5 minutes per pig bun. 5) Individual exposure concentration measurement of workers In this test, the reagent reagent dilution ratio was 25 times, 50 times, 1
The individual exposure concentration of glutaral in workers in 00 times spraying work was 0.24ppm, 0.18ppm,
The exposure concentration was 0.1 ppm, and the lower the dilution ratio, the higher the exposure concentration. It was necessary to wear protective equipment for exposure protection, but no abnormalities were observed in the workers.

【0029】上記から、10〜100倍希釈液を、豚舎
100坪に対して0.5〜10L煙霧することが適当と
判断された。
From the above, it was determined that it was appropriate to apply a 10 to 100-fold diluted solution to a pig barn of 100 tsubo in an amount of 0.5 to 10 L.

【0030】試験例III 希釈液における空気中濃度の経時変化測定試験 試験例II2)の各希釈倍数希釈液を豚舎に煙霧した場
合におけるグルタラールの空気中濃度の変動について調
べたところ、図1に示すように、25倍希釈、50倍希
釈、100倍希釈はいずれも散布直後では幾何平均濃度
が最も高値であり、散布1時間後において25倍希釈、
50倍希釈では散布直後の30%以下、100倍希釈で
は60%以下の値となった。散布3時間後には全ての希
釈倍数において幾何平均濃度は0.02ppm(検出限
界未満)となった。また24時間後も0.02ppmで
あった。
Test Example III Measurement Test of Time-Dependent Change in Concentration in Air of Diluted Solution When the diluting solutions of Test Example II2) were sprayed into a pig pen, fluctuations in the air concentration of glutaral were examined. The results are shown in FIG. Thus, the 25-fold dilution, the 50-fold dilution, and the 100-fold dilution all had the highest geometric mean concentration immediately after spraying, and 25 hours diluted 1 hour after spraying,
When diluted 50 times, the value was 30% or less immediately after spraying, and when diluted 100 times, the value was 60% or less. Three hours after spraying, the geometric mean concentration was 0.02 ppm (below the detection limit) at all dilution factors. It was still 0.02 ppm after 24 hours.

【0031】試験例IV グルタラールとホルマリンの毒性比較 本発明に用いるグルタラールとホルマリンとの毒性比較
を行った。その結果を表5及び表6に示す。
Test Example IV Toxicity Comparison between Glutaral and Formalin Toxicity comparison between glutaral and formalin used in the present invention was carried out. The results are shown in Tables 5 and 6.

【表5】 グルタラール100%換算[Table 5] Glutaral 100% conversion

【0032】[0032]

【表6】 グルタラールは液状であり吸入することがなく、毒性も
低く、安心して使用できるが、ホルマリンは常温でガス
状であるため、作業者は吸入して危険である。
[Table 6] Glutaral is a liquid, does not inhale, has low toxicity, and can be used safely, but formalin is gaseous at room temperature and is dangerous for workers to inhale.

【0033】試験例V 発症病変豚の治療効果試験 予め発症病変の豚を入れた豚舎に、試験例Iと同一の条
件で希釈液を煙霧する試験を2回行ったところ、成績は
下記の通りであった。試験その1では、20頭の発症病
変豚に対して煙霧した場合、対照は20頭中14頭の発
症病変豚が確認されたが、本発明では1頭に減少し、豚
の体重も増加し経済効果をあげることができた。試験そ
の2では、28頭の発症病変豚に対して煙霧した場合、
対照は18頭中12頭の発症病変豚が発見されたが、本
発明では1頭に減少し、体重も増加し飼料要求率の改善
及び出荷日令の短縮など経済効果をあげることができ
た。
Test Example V Therapeutic effect test of pigs with onset lesions A pig house containing pigs with onset lesions was subjected to the test of spraying the diluted solution twice under the same conditions as in Test Example I. The results are as follows. Met. In Test 1, when fogging was performed on 20 affected lesion pigs, 14 of the 20 affected lesion pigs were identified as controls, but in the present invention, the number of pigs was reduced to 1 and the weight of the pig was also increased. The economic effect was improved. In Test 2, when fumes were applied to 28 affected lesion pigs,
As a control, 12 out of 18 affected pigs were found, but in the present invention, the number was reduced to one, the weight was increased, and the economic effect such as improvement of feed conversion rate and shortening of shipping date could be achieved. .

【0034】また、豚の鼻甲介におけるAR病変のある
豚舎において、グルタラール70倍希釈液を豚舎100
坪に対して20L煙霧したところ、重度病変豚は9頭中
4頭に減少し、よってAR病(萎縮性鼻炎)にも治療効
果を発揮することが判明した。
Further, in a pig house having an AR lesion in the turbinate of the pig, a 70-fold dilution of glutaral was applied to a pig house 100 times.
When 20 L of smoke was applied to the tsubo, the number of severely affected pigs decreased to 4 out of 9 pigs, and it was found that the pigs also exhibited a therapeutic effect on AR disease (atrophic rhinitis).

【0035】<実施例> 実施例1 グルタクリーンの主剤グルタラール200m
Lに緩衝剤200g(炭酸水素ナトリウム120g、炭
酸ナトリウム80g)を添加して更に水を加えて2Lと
し、10倍希釈液とした。
<Example> Example 1 Glutaral 200 m, the main ingredient of Glutaclean
200 g of buffer (120 g of sodium bicarbonate, 80 g of sodium carbonate) was added to L, and water was further added to make 2 L to make a 10-fold diluted solution.

【0036】実施例2 グルターZの主剤グルタラール
200mLに緩衝剤200mLを加え、更に水を加えて
20Lとし、100倍希釈液とした。
Example 2 200 ml of a buffering agent was added to 200 ml of a main ingredient of Gluter Z, glutaral, and water was further added to make 20 liters to prepare a 100-fold diluted solution.

【0037】実施例3 豚の肺炎病変のある豚舎に、実
施例1の希釈液を豚舎100坪に対して0.5L煙霧し
たところ、煙霧によらず噴霧又は細霧とした対照区に比
較し78.2%の病気の軽減があった。
Example 3 In a pig house with a pneumonia lesion in a pig, 0.5 L of the diluted solution of Example 1 was sprayed with respect to 100 tsubo of the pig house. There was a 78.2% reduction in disease.

【0038】実施例4 豚の肺炎病変のある豚舎に、実
施例2の希釈液を豚舎100坪に対して2L煙霧したと
ころ、噴霧又は細霧とした対照区に比較して77.2%
の病気の軽減があり、体重も増加し経済的効果を発揮し
た。
Example 4 When 2 L of the diluted solution of Example 2 was sprayed into a pig house having a pneumonia lesion in a pig with respect to 100 tsubo of the pig house, it was 77.2% as compared with the control group which was sprayed or atomized.
The disease was alleviated, the weight gained and the economic effect was exhibited.

【0039】実施例5 豚のA.PP(アクチノバチル
スプルロニューモニエ)の恐れのある豚舎に、グルタラ
ール10倍希釈液を豚舎100坪に対して2L煙霧した
ところ、重度症状の豚3頭は0に、軽度症状2頭も0と
なり、A.PPの抑制が完全に認められ、発育の促進・
飼料要求率も改善された。
Example 5 Pig A. When 2L of 10 times diluted glutaral diluted solution was sprayed to 100 tsubo of a pig house in a pig house with the risk of PP (Actinobacillus pleuropneumoniae), 3 pigs with severe symptoms were 0, 2 pigs with mild symptoms were also 0, A. Suppression of PP is completely recognized, and promotion of growth
Feed conversion rates have also improved.

【0040】実施例6 豚の呼吸器病の恐れのある豚舎
において、グルタラール50倍希釈液を豚舎100坪に
対して5L煙霧したところ、噴霧又は細霧とした対照区
に比較して77.6%の豚に体重増加があった。
Example 6 In a pig house where there is a risk of respiratory disease in pigs, 5 L of a 50-fold diluted glutaral solution was sprayed on 100 tsubo of a pig house, and compared with the control group which was sprayed or atomized, it was 77.6. % Of pigs gained weight.

【0041】実施例7 豚の鼻甲介におけるAR病変の
ある豚舎において、グルタラール100倍希釈液を豚舎
100坪に対して10L煙霧したところ、発症病変豚は
9頭中4頭に減少し治療効果を発揮した。
Example 7 In a pig house with AR lesions in the turbinates of pigs, when a 100-fold dilution of glutaral was inhaled in a volume of 10 L per 100 tsubo of the pig house, the number of affected lesion pigs was reduced to 4 out of 9 pigs, and the therapeutic effect was reduced. Demonstrated.

【0042】[0042]

【発明の効果】以上詳述したように、本発明はグルタラ
ールを10〜100倍量に希釈し、豚舎100坪当り、
0.5〜10L煙霧することにより、豚の呼吸器病の起
因菌を死滅させ、その結果へい死淘汰率の減少、肺及び
鼻腔の病変軽減が認められ、その結果発育の促進、飼料
要求率の改善及び出荷日令の短縮など経済的効果をあげ
ることができ、また豚の呼吸器病を予防することもでき
る優れた効果を奏し得る。
As described above in detail, according to the present invention, glutaral is diluted to 10 to 100 times the amount thereof,
By inhaling 0.5 to 10 L of smoke, bacteria causing respiratory diseases of pigs are killed, resulting in reduction of mortality and selection of lung and nasal lesions, resulting in promotion of growth and improvement of feed requirement rate. Economic effects such as improvement and shortening of shipping date can be achieved, and excellent effects of preventing respiratory disease in pigs can be achieved.

【手続補正書】[Procedure amendment]

【提出日】平成6年12月14日[Submission date] December 14, 1994

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0030[Name of item to be corrected] 0030

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0030】試験例III 希釈液における空気中濃度の経時変化測定試験 試験例II2)の各希釈倍数希釈液を豚舎に煙霧した場
合におけるグルタラールの空気中濃度の変動について調
べたところ、25倍希釈、50倍希釈、100倍希釈は
いずれも散布直後では幾何平均濃度が最も高値であり、
散布1時間後において25倍希釈、50倍希釈では散布
直後の30%以下、100倍希釈では60%以下の値と
なった。散布3時間後には全ての希釈倍数において幾何
平均濃度は0.02ppm(検出限界未満)となった。
また24時間後も0.02ppmであった。
[0030] When each dilution dilution of aging Measurement Test Test Example II2) of Air Concentration in Test Example III dilutions were examined for variations in air concentrations glutaral in case of fumes pig house, 2 5-fold dilution , 50 times and 100 times dilution all have the highest geometric mean concentration immediately after spraying,
One hour after the application, the dilution was 25 times, the 50 times dilution was 30% or less immediately after the application, and the 100 times dilution was 60% or less. Three hours after spraying, the geometric mean concentration was 0.02 ppm (below the detection limit) at all dilution factors.
It was still 0.02 ppm after 24 hours.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 佐藤 洋一 福島県郡山市安積町成田字塊切山2−5− 12 (72)発明者 齋賀 丈範 神奈川県川崎市高津区二子757番1 ヤシ マ産業株式会社内 (72)発明者 椿 洋一郎 神奈川県川崎市高津区二子757番1 ヤシ マ産業株式会社内 (72)発明者 高田 純一 神奈川県川崎市高津区二子757番1 ヤシ マ産業株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Yoichi Sato 2-5-12 Tabatagiriyama, Narita, Azumi-cho, Koriyama-shi, Fukushima Prefecture (72) Takenori Saiga 757-1, Futako, Takatsu-ku, Kawasaki-shi, Kanagawa Yashima Sangyo Incorporated (72) Inventor Yoichiro Tsubaki, 757-1, Futako, Takatsu-ku, Kawasaki, Kanagawa, Yashima Sangyo Co., Ltd. (72) Inventor, Junichi Takada, 757-1, Futako, Takatsu, Kawasaki, Kanagawa, Yashima Sangyo, Ltd.

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 消毒剤グルタラールを緩衝剤を加えた水
で希釈し、得られた希釈液を煙霧機又は高圧微細機を用
いて粒子径10μ以下で煙霧し、豚に吸引させることに
より豚の下部気道の呼吸性気管支、更に肺胞まで煙霧粒
子を侵入させて、豚に常在する呼吸器病起因菌M.hn
(マイコプラズマ・ハイオニューモニエ)、P.m(パ
スツレラ・マルトシダ)、A.PP(アクチノバチルス
プルロニューモニエ)、H.PS(ヘモフィルスパラス
イス)、B.b(ボルデテーラブロンキセプテカ)等を
死滅させることを特徴とする豚の呼吸器病の治療方法。
1. The disinfectant glutaral is diluted with water to which a buffer is added, and the resulting diluted solution is atomized to a particle size of 10 μm or less using a fog machine or a high-pressure micromachine and sucked by the pig. The respiratory tract bronchi in the lower respiratory tract, and further infiltrate fumes into the alveoli, causing the respiratory bacterium M. hn
(Mycoplasma hyopneumoniae), P. m (pasturera maltocida), A. PP (Actinobacillus pleuropneumoniae), H.P. PS (Hemophilus parasuisse), B.I. A method for treating respiratory disease in pigs, which comprises killing b (bordetera bronxeptheca) and the like.
【請求項2】 グルタラール25%含有製剤を、該グル
タラール製剤と略等量の緩衝剤を加えた水で10〜10
0倍に希釈した希釈液を用いることを特徴とする請求項
1に記載の豚の呼吸器病の治療方法。
2. A formulation containing 25% of glutaral is added with water containing a buffering agent in an amount approximately equal to that of the glutaral formulation, and the mixture is added to 10 to 10 parts of water.
The method for treating respiratory disease in pigs according to claim 1, wherein a dilute solution diluted to 0-fold is used.
【請求項3】 豚舎100坪当り調整した希釈液を0.
5L〜10L程度煙霧することを特徴とする請求項1又
は2に記載の豚の呼吸器病の治療方法。
3. The diluent prepared per 100 tsubo of pork house is diluted with 0.1 g
The method for treating swine respiratory disease according to claim 1 or 2, wherein fumes of about 5 L to 10 L are produced.
【請求項4】 請求項1又は2又は3の方法を定期的に
実施することにより豚の呼吸器病を予防することを特徴
とする豚の呼吸器病の予防方法。
4. A method for preventing respiratory disease in pigs, which comprises periodically performing the method according to claim 1, 2 or 3 to prevent respiratory disease in pigs.
【請求項5】 粒子径10μ以下で煙霧し豚に吸引させ
ることにより豚の下部気道の呼吸性気管支、更に肺胞ま
で煙霧粒子を侵入させて、豚に常在する呼吸器病起因菌
M.hn(マイコプラズマ・ハイオニューモニエ)、
P.m(パスツレラ・マルトシダ)、A.PP(アクチ
ノバチルスプルロニューモニエ)、H.PS(ヘモフィ
ルスパラスイス)、B.b(ボルデテーラブロンキセプ
テカ)等を死滅させるための治療剤であって、グルタラ
ール25%含有製剤を該グルタール製剤と略等量の緩衝
剤を加えた水で10〜100倍に希釈してなることを特
徴とする豚の呼吸器病の治療剤。
5. A respiratory disease-causing bacterium that is resident in pigs, M. cerevisiae, is caused by inhaling the smoke particles with a particle diameter of 10 μm or less and inhaling them into the respiratory bronchi of the lower respiratory tract of the pigs and further into the alveoli. hn (Mycoplasma hyopneumoniae),
P. m (pasturera maltocida), A. PP (Actinobacillus pleuropneumoniae), H.P. PS (Hemophilus parasuisse), B.I. b (bordetera bronxepteca) and the like, which is a therapeutic agent for killing, etc., a 25% glutaral preparation is diluted 10 to 100-fold with water to which an approximately equivalent amount of a buffer is added. A therapeutic agent for respiratory disease in pigs characterized by being
JP29141894A 1994-11-25 1994-11-25 Method for treating / preventing respiratory disease in swine and therapeutic agent Expired - Fee Related JP2637703B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29141894A JP2637703B2 (en) 1994-11-25 1994-11-25 Method for treating / preventing respiratory disease in swine and therapeutic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29141894A JP2637703B2 (en) 1994-11-25 1994-11-25 Method for treating / preventing respiratory disease in swine and therapeutic agent

Publications (2)

Publication Number Publication Date
JPH08151323A true JPH08151323A (en) 1996-06-11
JP2637703B2 JP2637703B2 (en) 1997-08-06

Family

ID=17768630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29141894A Expired - Fee Related JP2637703B2 (en) 1994-11-25 1994-11-25 Method for treating / preventing respiratory disease in swine and therapeutic agent

Country Status (1)

Country Link
JP (1) JP2637703B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037090A1 (en) * 1998-12-18 2000-06-29 Fiona Woodcock Medicaments for the treatment of lung infections

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037090A1 (en) * 1998-12-18 2000-06-29 Fiona Woodcock Medicaments for the treatment of lung infections

Also Published As

Publication number Publication date
JP2637703B2 (en) 1997-08-06

Similar Documents

Publication Publication Date Title
KR100414699B1 (en) Dienucleotides useful for treating lung diseases
EP1955719B1 (en) Chlorine dioxide gas for use in treating respiratory virus infection
CN107072215A (en) There is the iodophor composition of improved stability in the presence of organic material
EP1686993B1 (en) Virucidal activities of a composition comprising cetylpyridinium chloride and citric acid
US20210352905A1 (en) Compositions and methods to disinfect, treat and prevent microbial infections
US20210252048A1 (en) Treatment of lung and airway diseases and disorders
JP2637703B2 (en) Method for treating / preventing respiratory disease in swine and therapeutic agent
US20220008456A1 (en) Compositions and methods to disinfect, treat and prevent microbial infections
KR20230077730A (en) Methods and Uses of Creating Compositions Stably Containing Free Available Chlorine Species and Peroxides
CN111437288A (en) Atomized molecular iodine disinfectant and application thereof
JP3084277B1 (en) Pig reproductive and respiratory disorder treatment drug
RU2571689C1 (en) Method of prevention and treatment of infectious diseases of birds
RU2097030C1 (en) Preparation for aerosol use for control over respiratory illnesses in animals and birds
RU2075974C1 (en) Preparation for aerosol treatment and prophylaxis of respiratory sickness in animals
US20240122971A1 (en) Compositions and methods for treatment and prevention of pathogens
RU2668377C1 (en) Disinfectant for premise treatment
WO2023021329A1 (en) Compositions and methods to disinfect, treat and prevent microbial infections
WO2024102951A2 (en) Compositions comprising stable free available chlorine species and peroxides, methods of making and uses thereof
RU2123355C1 (en) Disinfection agent
WO2022147585A1 (en) Formulations of a prophylactic nasal spray and methods of use and manufacture thereof
RU2252035C2 (en) Disinfectant
JP2024037185A (en) Livestock breeding methods and livestock feed
WO2022235781A1 (en) Treatment of lung and airway diseases and disorders
JP2023522398A (en) Pharmaceutical Compositions of Chlorine for Treatment of Respiratory Viral Infections
KR20210041672A (en) Composition with antibacterial effect containing silver ionic water

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080425

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 12

Free format text: PAYMENT UNTIL: 20090425

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090425

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090425

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090425

Year of fee payment: 12

LAPS Cancellation because of no payment of annual fees